BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1427 related articles for article (PubMed ID: 19226280)

  • 21. Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis.
    San Román B; Irache JM; Gómez S; Gamazo C; Espuelas S
    Int Arch Allergy Immunol; 2009; 149(2):111-8. PubMed ID: 19127067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunological and clinical effects of immunotherapy in patients suffering from house dust allergy.
    Chowdhury I; Chatterjee B
    Ann Agric Environ Med; 1999; 6(2):91-7. PubMed ID: 10607989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytosine-phosphate-guanine motifs fail to promote T-helper type 1-polarized responses in human neonatal mononuclear cells.
    Prescott SL; Irwin S; Taylor A; Roper J; Dunstan J; Upham JW; Burgner D; Richmond P
    Clin Exp Allergy; 2005 Mar; 35(3):358-66. PubMed ID: 15784116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The performance of a component-based allergen-microarray in clinical practice.
    Wöhrl S; Vigl K; Zehetmayer S; Hiller R; Jarisch R; Prinz M; Stingl G; Kopp T
    Allergy; 2006 May; 61(5):633-9. PubMed ID: 16629796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological effects and tolerability of a new fast updosed immunologically enhanced subcutaneous immunotherapy formulation with optimized allergen/adjuvant ratio.
    Pfaar O; Jung K; Wolf H; Decot E; Kleine-Tebbe J; Klimek L; Wüstenberg E
    Allergy; 2012 May; 67(5):630-7. PubMed ID: 22385366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.
    Bergmann KC; Demoly P; Worm M; Fokkens WJ; Carrillo T; Tabar AI; Nguyen H; Montagut A; Zeldin RK
    J Allergy Clin Immunol; 2014 Jun; 133(6):1608-14.e6. PubMed ID: 24388010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy.
    Di Lorenzo G; Mansueto P; Pacor ML; Rizzo M; Castello F; Martinelli N; Ditta V; Lo Bianco C; Leto-Barone MS; D'Alcamo A; Di Fede G; Rini GB; Ditto AM
    J Allergy Clin Immunol; 2009 May; 123(5):1103-10, 1110.e1-4. PubMed ID: 19356792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of specific immunotherapy to mosquito bites.
    Ariano R; Panzani RC
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):131-8. PubMed ID: 15180354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
    Schubert R; Eickmeier O; Garn H; Baer PC; Mueller T; Schulze J; Rose MA; Rosewich M; Renz H; Zielen S
    Int Arch Allergy Immunol; 2009; 148(3):251-60. PubMed ID: 18849616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.
    Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD
    Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
    Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal versus postnatal sensitization to environmental allergens in a high-risk birth cohort.
    Rowe J; Kusel M; Holt BJ; Suriyaarachchi D; Serralha M; Hollams E; Yerkovich ST; Subrata LS; Ladyman C; Sadowska A; Gillett J; Fisher E; Loh R; Soderstrom L; Ahlstedt S; Sly PD; Holt PG
    J Allergy Clin Immunol; 2007 May; 119(5):1164-73. PubMed ID: 17412403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
    Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
    Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and tolerability of immunotherapy using various updosing schedules of a new SCIT product with an optimised allergen/aluminium hydroxide ratio.
    Jung K
    Allergy; 2011 Jul; 66 Suppl 95():41-3. PubMed ID: 21668852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse allergen-specific immunoglobulin G and immunoglobulin G4 and allergic symptoms in immunoglobulin E-sensitized laboratory animal workers.
    Matsui EC; Diette GB; Krop EJ; Aalberse RC; Smith AL; Curtin-Brosnan J; Eggleston PA
    Clin Exp Allergy; 2005 Oct; 35(10):1347-53. PubMed ID: 16238795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens].
    Silny W; Czarnecka-Operacz M; Silny P
    Wiad Lek; 2005; 58(3-4):184-92. PubMed ID: 16119162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.